Sunir J. Garg, MD, is Professor of Ophthalmology at the Retina Service of Wills Eye Hospital, Thomas Jefferson University, and is a partner with Mid Atlantic Retina. He is co-director of the Retina Research Unit at Wills Eye Hospital. He has published more than 400 peer reviewed papers, book chapters, and commentaries, and is editor of ophthalmology for the Merck Manual, Deputy Editor in Chief of the American Academy of Ophthalmology ONE Network, outgoing Editor-in-Chief of Retina Times, and a member of the Editorial Boards of the American Journal of Ophthalmology and the Canadian Journal of Ophthalmology. He is also an official clinical spokesperson for the American Academy of Ophthalmology.
Dr. Garg has been featured in the Wall Street Journal, USA Today, the Philadelphia Inquirer, Popular Science, The Atlantic, Women’s Health, and has been on Good Morning America, the Today Show, and the Canadian Broadcasting Corporation.
Financial disclosure: Dr. Garg has/had an affiliation (financial or otherwise) with a commercial organization:
- Apellis
- Bausch & Lomb
- Boehringer lngelheim
- Coherus
- Genentech
- Kanaph
- Kodiak Biosciences
- Merck Manual
- NGM Bio
- Regeneron
Sessions in which Sunir J. Garg, MD, FACS, FASRS participates
Friday 16 June, 2023
Learning Objectives: At the end of this session, participants will be able to: Understand the concept of retinal displacement in retinal detachment repair and the various factors affecting itAssess the use of multi-modal imaging technologies to optimize surgical resultsIntegrate peripheral retinal imaging in the assessment of retinal pathologiesCanMEDS Roles:
Learning Objectives: At the end of this session, participants will be able to: Assess new therapeutic modalities for dry age-related macular degenerationAssess current therapies for wet age-related macular degenerationAssess complications of anti-VGF treatments and preventative measuresCanMEDS Roles: Medical Expert, Scholar
Learning Objectives: At the end of this session, participants will be able to: Assess the use of multi-modal imaging in assessing retinal pathologyAssess new technologies in imaging of the retinaIntegrate new management strategies for diabetic retinopathyCanMEDS Roles: Medical Expert, Scholar
Saturday 17 June, 2023
*Breakfast to be served from 6:00am* Learning Objectives: At the end of this session, participants will be able to: Outline the role of the Tie-2/ang pathway in DR and nAMDand how it may impact patient outcomesIdentify the most important biomarkerson structural OCT that can help predict treatmentresponse in DME and nAMDDiscuss r...
Learning Objectives:At the end of this session, participants will be able to:Elucidate the cause and mechanism of DVD.Identity indications of Light adjustable lensXX
Learning Objectives: At the end of this session, participants will be able to: Identify Imaging Signs & Biomarkers for ongoing anti-VEGF treatmentIdentify and review pathognomonic imaging features of Inherited Retinal DiseaseReview unique retinal imaging findings in uncommon retinal conditions